Zobrazeno 1 - 9
of 9
pro vyhledávání: '"George Crotts"'
Autor:
Klaus Wuchner, Linda Yi, Cyrille Chery, Felix Nikels, Friederike Junge, George Crotts, Gianluca Rinaldi, Jason A. Starkey, Karoline Bechtold-Peters, Melissa Shuman, Michael Leiss, Michael Jahn, Patrick Garidel, Rien de Ruiter, Sarah M. Richer, Shawn Cao, Sebastian Peuker, Sylvain Huille, Tingting Wang, Virginie Le Brun
Publikováno v:
Journal of Pharmaceutical Sciences. 111:2955-2967
Polysorbate (PS) 20 and 80 are the main surfactants used to stabilize biopharmaceutical products. Industry practices on various aspects of PS based on a confidential survey and following discussions by 16 globally acting major biotechnology companies
Autor:
Klaus Wuchner, Linda Yi, Cyrille Chery, Felix Nikels, Friederike Junge, George Crotts, Gianluca Rinaldi, Jason A. Starkey, Karoline Bechtold-Peters, Melissa Shuman, Michael Leiss, Michael Jahn, Patrick Garidel, Rien de Ruiter, Sarah M Richer, Shawn Cao, Sebastian Peuker, Sylvain Huille, Tingting Wang, Virginie Le Brun
Publikováno v:
Journal of pharmaceutical sciences. 111(5)
Polysorbates (PS) are widely used as a stabilizer in biopharmaceutical products. Industry practices on various aspects of PS are presented in this part 1 survey report based on a confidential survey and following discussions by 16 globally acting maj
Autor:
Shubhadra N. Singh, George Crotts, Tanvir Tabish, Qingyan Hu, Brittney J. Mills, Lori S. Burton, Douglas E. Kamen, Hodge Tamara Shafer, Yongmei Wu, Francisca O. Gbormittah, Sonal Saluja, Elaine S.E. Stokes, Kevin Muthurania, Adithi C. Bhargava, Chakravarthy Nachu Narasimhan, Ligi Mathews
Publikováno v:
Journal of pharmaceutical sciences. 111(4)
In-use stability and compatibility studies are often used in biotherapeutic development to assess stability and compatibility of biologic drugs with diluents and/or administration components at relevant conditions for the target route of administrati
Autor:
Peter M. Ihnat, Katherine Taylor, Chakravarthy Nachu Narasimhan, Dingjiang Liu, Valentyn Antochshuk, Jason E. Fernandez, Kapil Gupta, Daniel Dix, Eric Routhier, Elaine S.E. Stokes, Truong Nobel T, Sorina Morar-Mitrica, Fleming Michael, James K. Kranz, Diluzio Willow, Christine Wurth, George Crotts, Bing He, Monica L. Adams, Tanvir Tabish
Publikováno v:
Journal of pharmaceutical sciences. 107(2)
The Biophorum Development Group (BPDG) is an industry-wide consortium enabling networking and sharing of best practices for the development of biopharmaceuticals. To gain a better understanding of current industry approaches for establishing biopharm
Autor:
Douglas P. Nesta, Ping Hu, Alexandra Beumer Sassi, George Crotts, Sorina Morar-Mitrica, Joshua Fuller, Manasi Puri
Publikováno v:
mAbs. 7(4)
The physical and chemical integrity of a biopharmaceutical must be maintained not only during long-term storage but also during administration. Specifically for the intravenous (i.v.) delivery of a protein drug, loss of stability can occur when the p
Publikováno v:
Journal of Controlled Release. 47:101-111
A model protein, carboxymethylated bovine serum albumin (CM-BSA), was encapsulated within relatively fast degrading and slow degrading poly(d,l-lactide-co-glycolide, PLGA) microspheres using a multiple emulsion solvent evaporation technique. The spec
Autor:
George Crotts, Tae Gwan Park
Publikováno v:
Journal of Controlled Release. 44:123-134
Various factors affecting the stability and release of a model protein, bovine serum albumin (BSA), encapsulated within biodegradable poly( d , l -lactide-co-glycolide) microparticles were examined in detail. Size exclusion chromatographic analysis o
Autor:
Tae Gwan Park, George Crotts
Publikováno v:
Journal of Controlled Release. 35:91-105
A simple method to prepare various porous and nonporous hollow microspheres composed of poly( d,l -lactic-co-glycolic acid) using a water/oil/water (W/O/W) multiple emulsion solvent evaporation technique is described. The volume of the inner aqueous
Publikováno v:
Journal of Controlled Release. 33:211-222
Two proteins, carbonic anhydrase (Mr 31 000) and bovine serum albumin (Mr 66 000), have been encapsulated as model protein drugs within microspheres composed of relatively fast degrading poly(d,l-lactic acid-co-glycolic acid, 50/50). The microspheres